These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21748647)

  • 1. Synthesis, purification, and characterization of immune-modulatory oligodeoxynucleotides that act as agonists of Toll-like receptor 9.
    Putta MR; Yu D; Kandimalla ER
    Methods Mol Biol; 2011; 764():263-77. PubMed ID: 21748647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8.
    Lan T; Kandimalla ER
    Methods Mol Biol; 2011; 764():249-61. PubMed ID: 21748646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nature and length of linker incorporated in agonists on toll-like receptor 9-mediated immune responses.
    Putta MR; Yu D; Bhagat L; Wang D; Zhu FG; Kandimalla ER
    J Med Chem; 2010 May; 53(9):3730-8. PubMed ID: 20361743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation.
    Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Versatile linker chemistry for synthesis of 3'-modified DNA.
    Lyttle MH; Adams H; Hudson D; Cook RM
    Bioconjug Chem; 1997; 8(2):193-8. PubMed ID: 9095360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice.
    Zhu FG; Kandimalla ER; Yu D; Agrawal S
    J Allergy Clin Immunol; 2007 Sep; 120(3):631-7. PubMed ID: 17582479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
    Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase chemical synthesis of phosphonoacetate and thiophosphonoacetate oligodeoxynucleotides.
    Dellinger DJ; Sheehan DM; Christensen NK; Lindberg JG; Caruthers MH
    J Am Chem Soc; 2003 Jan; 125(4):940-50. PubMed ID: 12537492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines.
    Daubenberger CA
    Curr Opin Mol Ther; 2007 Feb; 9(1):45-52. PubMed ID: 17330401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC analysis of synthetic oligonucleotides using spectral contrast techniques.
    Warren WJ; Stanick WA; Gorenstein MV; Young PM
    Biotechniques; 1995 Feb; 18(2):282-7. PubMed ID: 7727131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
    Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
    J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
    Wang D; Bhagat L; Yu D; Zhu FG; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Jan; 52(2):551-8. PubMed ID: 19102653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of synthetic oligodeoxyribonucleotides by capillary gel electrophoresis and anion-exchange HPLC.
    Warren WJ; Vella G
    Biotechniques; 1993 Apr; 14(4):598-606. PubMed ID: 8476604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and purification of synthetic large oligodeoxyribonucleotides by HPLC on RPC-5 like resin.
    Sawai H
    Nucleic Acids Symp Ser; 1986; (17):113-6. PubMed ID: 3562255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D; Jung J; Lee Y; Kwon HJ
    Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and immunological activities of novel agonists of toll-like receptor 9.
    Struthers M; Bett AJ; Wisniewski T; Dubey SA; Precopio M; Jiang W; Sun Z; Wang H; Nowak I; Putta MR; Yu D; Tang JX; Kandimalla ER; Agrawal S; Casimiro DR
    Cell Immunol; 2010; 263(1):105-13. PubMed ID: 20381019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
    Ravikumar VT; Kumar RK; Capaldi DC; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.